<DOC>
	<DOC>NCT00310466</DOC>
	<brief_summary>The trial is performed to assess the efficacy and safety of SLIT One birch for treatment of birch pollen induced allergy</brief_summary>
	<brief_title>Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever</brief_title>
	<detailed_description>Daily rhinoconjunctivits symptom and medication scores from patient diaries, adverse events</detailed_description>
	<criteria>A history of birch pollen allergy Positive skin prick test to birch Positive conjunctival test to birch Positive specific Immunoglobulin E (IgE) to birch Forced expiratory volume in 1 second (FEV1)&lt;70% of predicted value History of seasonal allergy interfering with study History of symptomatic perennial allergy History of emergency visit or admission for asthma in the previous 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>